Accendra Health
227 hedge funds and large institutions have $1.5B invested in Accendra Health in 2023 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 68 increasing their positions, 90 reducing their positions, and 21 closing their positions.
90% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 21
14% more capital invested
Capital invested by funds: $1.31B → $1.5B (+$189M)
8% more funds holding
Funds holding: 210 → 227 (+17)
4.31% less ownership
Funds ownership: 106.26% → 101.95% (-4.3%)
24% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 90
53% less call options, than puts
Call options by funds: $3.16M | Put options by funds: $6.69M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$34.5M |
| 2 |
BlackRock
New York
|
+$8.5M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$6.95M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.92M |
| 5 |
Millennium Management
New York
|
+$4.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$45.5M |
| 2 |
DM
Deerfield Management
New York
|
-$21.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$19M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$14.6M |
| 5 |
Goldman Sachs
New York
|
-$11.1M |
ACH Hedge Fund Activity: Q4 2023 in Review
227 of the 6,872 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q4 2023, worth a combined $1.5B — up 14% from $1.31B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new ACH positions and 21 closed out — a net gain of 19 holders — while 68 added to existing stakes and 90 trimmed.
The largest buyer was Pacer Advisors, adding an estimated $34.5M. The largest seller was Wellington Management Group, cutting an estimated $45.5M.
- 227 institutional investors held Accendra Health (ACH) as of Q4 2023, up from 210 in Q3 2023.
- Funds reported $1.5B of Accendra Health stock for Q4 2023, up 14% quarter-over-quarter.
- 40 funds opened new Accendra Health positions in Q4 2023 and 21 closed out, a net change of +19 holders.
- The largest Accendra Health buyer in Q4 2023 was Pacer Advisors, an estimated $34.5M added.
- The largest Accendra Health seller in Q4 2023 was Wellington Management Group, an estimated $45.5M sold.
Based on aggregated 13F filings for Q4 2023.